Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[18F]FTC-146 PET/MRI in Chronic Pain
NCT03556137Phase 1Unknown
- Sponsor
- Stanford University
- Start
- Jul 2018
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of [18F]-FTC-146 in neuropathic pain, nociceptive pain, mixed pain and 4 more (2 arms), sponsored by Stanford University. Primary endpoints: [18F]FTC-146 Biodistribution in Healthy Volunteers at 3 hours and [18F]FTC-146 Biodistribution in Pain Patients at 3 hours. Status: unknown.
02
Drugs
[18F]-FTC-146
03
Conditions
neuropathic painnociceptive painmixed painSpinal painradiculopathy
Beyond the preview
Go deeper on NCT03556137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03556137.